$RNAZ Income Statement | Understand Stock

$RNAZ

$1.67 -$0.04 (2.08%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating expenses
Research and development
General and administrative
General and administrative expenses
Acquisition-related transaction costs
Total general and administrative
Total operating expenses
Operating loss
Other income (expense)
Change in fair value of derivative liabilities
Change in fair value of warrant liabilities
Change in fair value of contingent consideration
PIPE warrant Issuance Costs
Grant income
Loss on sale of equipment
Gain on sale of equipment
Currency exchange gain (loss)
Interest income
Interest expense
Total other income (expense)

Loss before income taxes
Deferred income tax provision
Net Loss
Deemed dividend arising from warrant modification
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock
Net loss attributable to common stockholders
Net loss attributable to common stockholders, diluted
Weighted-average common shares outstanding, Basic
Weighted-average common shares outstanding, Diluted
Net loss per share, Basic
Net loss per share, Diluted

Comments